Special Announcement - Now Screening for FDA Approved Stem Cell Study
Dr. Mitchell Sheinkop has completed training and is credentialed for an FDA-approved stem cell clinical trial for knee arthritis. Our clinic is now screening patients for this trial. Contact us at 312-475-1893 for details. Click here to learn more.

I started the day by reading the Steve Chapman article appearing in the Perspective Section of the Chicago Tribune, Thursday December 8. The title of my Blog this week is influenced by the header of his article and I admit I am paraphrasing some of that content. While his intent was not necessarily directed at the discipline of Regenerative Medicine, his statement” since the advent of the internet, truth doesn’t have a chance” really resonates with me. He goes on to state that in many of these internet claims, the idea of objective reality is obliterated. “The chief product is fiction masquerading as fact.”

Unfortunately, while Chapman was rendering his opinion in the political arena, what he opines is just as applicable in the world of Regenerative; but there are exceptions. As many readers of this Blog are aware, I have an existing web site www.sheinkopmd.com. I have tried to continually emphasize and repeat the Regenexx message; namely, that which we do is based on data, the integration of a clinical practice with a clinical research initiative. Yesterday, we forwarded our two-year outcomes data to Regenexx for statistical analysis. That data has been compiled in a clinical knee trial over the past four years wherein the Regenexx SD procedure was used in 50 patients with grades two and three osteoarthritis of the knee who met the inclusion criteria. Once statistically analyzed, I will submit that data for scientific publication, scientific presentation and it will be published on the Regenexx and my web sites.

To emphasize why it is so important for a patient experiencing arthritic related limitations be fully educated, let me share with you a relevant research letter recently published:

Survey: Many treatments prescribed despite little evidence of high value to patients.

Information from a research letter published in the Dec. 6 issue of the journal Annals of Surgery wherein researchers randomly surveyed 5,000 members of the American College of Physicians found that many prescribe costly treatments despite a lack of evidence supporting their use.

In surveying the internet this morning to see how badly fiction is masquerading as fact, I didn’t have to surf too far. The number of camp follower, non-specialist stem cell related web sites are of great concern. I hope the FDA shares my opinion. You can find treatment for arthritis, cancer, aesthetics, hair loss, sexual enhancement, and neurologic diseases all with one stop shopping. The web sites offer adipose derived stem cells and amniotic fluid containing stem cells. Missing from the offerings are outcomes data, scientific support and FDA compliance. Regenexx does it and so do I; namely, practice cellular orthopedics on a scientific basis under IRB oversite (a function of the FDA) with all intervention recommendations supported by scientific evidence.

To learn more, schedule an appointment 312 475 1893.  You may view my webinar at ilcellulartherapy.com

Tags: , , , , , ,

Pin It on Pinterest

Share This